Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s Disease

Manuscript Number: 

17-0164R1

Author(s): 
Meghan K. Cash, Sultan Darvesh, Drew R. DeBay, Ian R. Macdonald, Selena P. Maxwell, George A. Reid

Disclosures

Meghan K. Cash

  • Nothing to Disclose

Sultan Darvesh

  • Equity:
    SD is a scientific co-founder and stockholder in Treventis Corporation, a biotech company focused on development of diagnostic and therapeutic agents for Alzheimer’s disease. No other potential conflict of interest relevant to this article

Drew R. DeBay

  • Nothing to Disclose

Ian R. Macdonald

  • Nothing to Disclose

Selena P. Maxwell

  • Nothing to Disclose

George A. Reid

  • Nothing to Disclose